NEW JOURNAL PUBLICATION
Managing the challenges of paying for gene therapy: strategies for market action and policy reform in the United States
New open access policy analysis from Institute for Clinical and Economic Review (ICER) and NEWDIGS Initiative at Tufts Medical Center analyzes the challenges and potential policy options for paying for gene therapies.
Read the open access paper
Recent news
Mara Palm joins NEWDIGS
Jul 18, 2024NEWDIGS leaders named to Illinois SCD Advisory Council
Jul 02, 2024ISPOR 2024 panel recap: Will the Pediatric Rare Disease Pipeline Create a Financial Tsunami? Implications of a Monte Carlo Projection
May 21, 2024BioCentury OpEd: Biomedical Innovation Requires Health System Innovation
May 14, 2024Managing the Challenges of Paying for Gene Therapy: New ICER / NEWDIGS whitepaper
Apr 23, 2024Our mission is to improve health outcomes by accelerating appropriate, timely, and equitable patient access to biomedical products in ways that work for all stakeholders.
We design and catalyze solutions with an integrated systems view through complementary approaches of public-private partnerships (our consortium), sponsored research, custom education, and experiential action learning.